Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • HOLLIS-EDEN PHARMACEUTICALS Financial Overview

  • Income Statement: HEPH

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 645,000.00 -645,000.00 -∞ T%
    Gross Profit -16.07 M -17.67 M 1.60 M -9.98%
    Net Income Before Extra Items/Preferred Div -21.56 M -23.12 M 1.56 M -7.22%
    Operating Income -22.61 M -25.82 M 3.22 M -14.23%
  • Cash Flow: HEPH

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 0.00 20,000.00 -20,000.00 -∞ T%
    Net Cash Flow - Investing 70,000.00 234,000.00 -164,000.00 -234.29%
    Net Cash Flow/Operating Activities -18.99 M -23.71 M 4.71 M -24.81%
  • Balance Sheet: HEPH

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 25.16 M 45.12 M -19.97 M -79.37%
    Total Liabilities 1.95 M 3.02 M -1.07 M -54.61%
    Shareholders Equity 23.20 M 42.10 M -18.90 M -81.45%
  • Key Ratios / Statistics: HEPH

    • Valuation

      Price/Earnings (TTM) -0.92
      Price/Sales (TTM) 70.47
      Price/Book (MRQ) 1.01
      Price/Cash Flow (TTM) -0.95
    • Profitability

      Gross Margin -2,740.16
      Operating Margin -4,003.72
      Profit Margin -3,584.65
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 12.38
      Current Ratio (MRQ) 8.59
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -65.86
      Return on Assets (TTM) -75.03
      Return on Investments (TTM) -66.04